MX2011008239A - Composicion farmaceutica solida que contiene sulfamato de 6-oxo-6,7,8,9,10,11-hexahidrociclohepta[c]cromen-3-ilo y sus polimorfos. - Google Patents

Composicion farmaceutica solida que contiene sulfamato de 6-oxo-6,7,8,9,10,11-hexahidrociclohepta[c]cromen-3-ilo y sus polimorfos.

Info

Publication number
MX2011008239A
MX2011008239A MX2011008239A MX2011008239A MX2011008239A MX 2011008239 A MX2011008239 A MX 2011008239A MX 2011008239 A MX2011008239 A MX 2011008239A MX 2011008239 A MX2011008239 A MX 2011008239A MX 2011008239 A MX2011008239 A MX 2011008239A
Authority
MX
Mexico
Prior art keywords
chromen
oxo
sulfamate
polymorphs
pharmaceutical composition
Prior art date
Application number
MX2011008239A
Other languages
English (en)
Inventor
Joel Richard
Barry Victor Lloyd Potter
Alain Rolland
Gerard Coquerel
Christian Diolez
Nathalie Mondoly
Bertrand Poirot
Anne Brochard
Delphine Delahaye
Francis Diancourt
Damien Martins
Julie Linol
Ophelie Houssin
Marie-Noelle Petit
Lok Wai Lawrence Woo
Original Assignee
Ipsen Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0900656A external-priority patent/FR2942226B1/fr
Priority claimed from FR0900655A external-priority patent/FR2942225B1/fr
Application filed by Ipsen Pharma Sas filed Critical Ipsen Pharma Sas
Publication of MX2011008239A publication Critical patent/MX2011008239A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica sólida que comprende el principio activo de sulfamato de 6-oxo-6,7,8,9,l0,11-hexahidrociclohepta[c]- cromen-3-ilo. La presente invención se refiere igualmente a los polimorfos del compuesto de sulfamato de 6-oxo- 6,7,8,9,10,11-hexahidrociclohepta [c] cromen-3-ilo.
MX2011008239A 2009-02-13 2010-02-12 Composicion farmaceutica solida que contiene sulfamato de 6-oxo-6,7,8,9,10,11-hexahidrociclohepta[c]cromen-3-ilo y sus polimorfos. MX2011008239A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0900656A FR2942226B1 (fr) 2009-02-13 2009-02-13 Nouveau polymorphe cristallin du 6-oxo+6,7,8,9,10,11-hexahydrocyclohepta°c!chromen-3-yl sulfamate
FR0900655A FR2942225B1 (fr) 2009-02-13 2009-02-13 Variete i du 6-oxo-6,7,8,9,10,11-hexahydroclyclohepta5°c!chromen-3 yl sulfamate de granulometrie reduite
PCT/FR2010/000117 WO2010092260A2 (fr) 2009-02-13 2010-02-12 Compositions pharmaceutiques du 6-oxo-6.7.8,9.10.11-hexahydrocyclohepta mchromen-3-yl sulfamate

Publications (1)

Publication Number Publication Date
MX2011008239A true MX2011008239A (es) 2011-09-06

Family

ID=42562120

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011008239A MX2011008239A (es) 2009-02-13 2010-02-12 Composicion farmaceutica solida que contiene sulfamato de 6-oxo-6,7,8,9,10,11-hexahidrociclohepta[c]cromen-3-ilo y sus polimorfos.

Country Status (10)

Country Link
EP (1) EP2396311A2 (es)
JP (1) JP2012517988A (es)
KR (1) KR20110115607A (es)
CN (1) CN102317276A (es)
AU (1) AU2010212753A1 (es)
BR (1) BRPI1008422A2 (es)
CA (1) CA2751393A1 (es)
MX (1) MX2011008239A (es)
RU (1) RU2011137516A (es)
WO (1) WO2010092260A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3592338A1 (en) * 2017-03-08 2020-01-15 ARIAD Pharmaceuticals, Inc. Pharmaceutical formulations comprising 5-chloro-n4

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9603325D0 (en) * 1996-02-16 1996-04-17 Imperial College A compound
US6921776B1 (en) * 1996-02-16 2005-07-26 Sterix Limited Compound
CN1309387C (zh) * 2003-04-15 2007-04-11 南昌弘益科技有限公司 溶出度得到提高的甲芬那酸分散片及其制备方法—镇痛、解热、抗炎药
GB0408308D0 (en) * 2004-04-14 2004-05-19 Vectura Ltd Pharmaceutical compositions
GB0511190D0 (en) * 2005-06-01 2005-07-06 Sterix Ltd Use
BRPI0717721A2 (pt) * 2006-11-28 2013-10-29 Marinus Pharmaceuticals "partículas complexadas de drogas, composição farmacêutica, uso de uma composição farmacêutica, partículas complexadas de droga estabilizadas no tamanho, método para a preparação de partículas estabilizadas da droga, composição farmacêutica sólida, comprimido oral ingerível e composição líquida em nanopartículas estabilizadas no tamanho"

Also Published As

Publication number Publication date
BRPI1008422A2 (pt) 2016-03-01
RU2011137516A (ru) 2013-03-20
AU2010212753A1 (en) 2011-09-01
WO2010092260A3 (fr) 2011-02-17
KR20110115607A (ko) 2011-10-21
CA2751393A1 (fr) 2010-08-19
WO2010092260A8 (fr) 2011-08-11
EP2396311A2 (fr) 2011-12-21
WO2010092260A2 (fr) 2010-08-19
CN102317276A (zh) 2012-01-11
JP2012517988A (ja) 2012-08-09

Similar Documents

Publication Publication Date Title
MX2010009646A (es) Agentes terapeuticos antivirales.
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
EP3699176A3 (en) Antiviral compounds
MX2010005889A (es) Derivados de tiofeno como agonistas de s1p1/edg1.
WO2010092090A3 (en) Novel salts of sitagliptin
PH12013502192A1 (en) Antibodies against human angiopoietin 2
TW200942524A (en) Novel aminomethyl benzene derivatives
WO2009005677A3 (en) Antiviral compounds
WO2009005676A3 (en) Antiviral compounds
WO2010036407A3 (en) Antiviral nucleoside analogs
MX2007008790A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso.
AU2010233994A8 (en) Bispecific anti-ErbB-3/anti-c-Met antibodies
MY183312A (en) Pharmaceutical formulation
MX2012007098A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
MX2012007161A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
TW200942530A (en) Pyridine compounds
WO2010049449A3 (en) Novel salts of sunitinib
MX2007006042A (es) Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion.
UA97401C2 (ru) Экструдат с улучшенной маскировкой вкуса
TN2012000105A1 (en) Spirolactam derivatives and uses of same
IN2012DN01292A (es)
WO2009062659A3 (en) Polymorphs of enantiopure erdosteine
MA34580B1 (fr) Valsartan hautement cristallin
MX2012002580A (es) Compuesto antibacteriano novedoso de hidroxifenilo.
WO2009034432A8 (en) Novel compounds active as muscarinic receptor antagonists

Legal Events

Date Code Title Description
FA Abandonment or withdrawal